The Cannabis Compliance Frontier: Insights from Kim Stuck at Cannabis Science Conference Spring 2024
In this quick, onsite interview, Program Chair of the Compliance Track, Kim Stuck, shares the biggest buzz from the Cannabis Science Conference Spring 2024.
Filmed live at Cannabis Science Conference in Kansas City, Missouri, Kim Stuck, the program chair for the new Compliance Track, shares what caught her attention at the conference. During this two-day event, Stuck also moderated the General Session panel discussion, “Federal Rescheduling: Opinions and Impacts from Various Sectors,” which featured panelists Susan Audino, S.A. Audino & Associates, LLC; Ken Sobel, ESQ; and David Vaillencourt, S3 Collective. Stuck is the founder and CEO of Allay Consulting, a cannabis consulting firm that deals with operational compliance and FDA, GMP, OSHA, and more, plus the author of the monthly Cannabis Science and Technology blog, Stuck on Compliance.
Watch our exclusive, onsite interview at the Cannabis Science and Technology booth and read the transcript below for more insights into the conference.
What has been the biggest development or innovation you have seen at this Cannabis Science Conference?
Kim Stuck: The main thing that I noticed was all of the talk of the rescheduling, because that literally happened a week before the conference that the DEA [Drug Enforcement Administration] announced rescheduling. So we actually had kind of an impromptu panel put together, that I got to moderate and it was really great. It was with me, David [Vaillencourt], and Susan [Audino], and Ken Sobel, and I feel like we touched on a whole lot of things, possibilities of what can happen because everything is still so up in the air, we have no idea really how they're gonna move forward with it yet. So, watching people's brains work and figure out, "okay, what are we going to do with our business from here until now," and all of that is always really fun for us. We have so many clients in the industry that are in that space freaking out, but they really shouldn't be. I think it's actually going to be a really great thing when it all comes together. I think that was the biggest buzz in the conference, was the rescheduling, so I'm excited to see what happens in the future.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.
